The Propark study is coordinated by the Leiden University Medical Center, Department of Neurology, Leiden, The Netherlands
 
SCOPA BACKGROUND
SCOPA SCALES
PROPARK BACKGROUND
LIST OF PUBLICATIONS
RESEARCH TEAM
PROJECTS
FINANCIAL SUPPORT
PROMISE DATABASE

E-MAIL
CONTACT
LOGIN

HOMEPAGE

© developed by dick jeukens
Publication
Titles and texts are only in English available.
Authors

Virués-Ortega J, Rodríguez-Blázquez C, Micheli F, Carod-Artal FJ, Serrano-Dueñas M, Martínez-Martín P.

Title
Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages.
Published in:
Mov Disord 2010 Mar 22. [Epub ahead of print]
Content
This study assessed the psychometric attributes of the modified Parkinson Psychosis Rating Scale (mPPRS). In an attempt to improve scale\'s scaling assumptions and content validity, all types of hallucinations were rated and all items were scored based on intensity. The scale was cross-culturally adapted to four Latin American countries (Argentina, Brazil, Ecuador, and Paraguay). Acceptability, internal consistency, factor structure, convergent and known-groups validity, and precision (standard error of measurement, SEM) were explored. A total of 388 patients with PD were included in the study (age, 64.5 +/- 10.7 years; 59.8% males; PD duration, 8.2 +/- 4.9 years). The mPPRS was highly usable in terms of missing values generated and scores distribution (total computable scores, 99.7%, ceiling effect, <15%). Scaling assumptions were acceptable as noted by the range of item-total correlations (0.14-0.55, only one coefficient below 0.2). Internal consistency was adequate for research use (Cronbach alpha, 0.7). Factor analysis identified two factors that accounted for 58.5% of the variance. Low correlation coefficients were found with cognitive function (SCOPA-Cog) and disease severity (CISI-PD) (r(S) </= 0.30), whereas correlation with psychosis were high (r(S) = 0.56). Known-groups validity analyses indicated a significant increase in mPPRS scores by Hoehn and Yahr stage (P < 0.001). The SEM value was 1.06. Overall, the results suggest that the mPPRS is a useful tool for evaluation of psychosis in PD. The results show that some psychometric properties of the mPPRS are satisfactory albeit there is room for the improvement of scale\'s content validity and internal consistency. (c) 2010 Movement Disorder Society.
Publications by other groups using SCOPA scales
List of publications
  Publications in 2010
Autonomic and cognitive functions in Parkinson's disease (PD).
Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease.
Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA).
Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages.
Heart rate variability in type 2 spinocerebellar ataxia.
Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease.
Psychometric properties of the SCOPA-AUT Brazilian Portuguese version.
Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease.
What contributes to driving ability in Parkinson's disease.

  Publications in 2009
Addenbrooke's Cognitive Examination validation in Parkinson's disease.
Assessing autonomic symptoms of Parkinson's disease with the SCOPA-AUT: a new perspective from Rasch analysis.
Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment.
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.
Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial.
Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease
Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT).
International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.
Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study
Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review
Should the SCOPA-COG be modified?: a Rasch analysis perspective.
The Clinical Impression of Severity Index for Parkinson's Disease: international validation study.

  Publications in 2008
Burden, perceived health status, and mood among caregivers of Parkinson's disease
Cross-Cultural Validation of the Scales for Outcomes in Parkinson's
Does implicit learning in non-demented Parkinson's disease depend on the level of cognitive functioning?
Longitudinal psychometric attributes, responsiveness, and importance of change:
Psychometric attributes of Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), Castilian language
Psychometric attributes of the SCOPA-COG Brazilian version.

  Publications in 2007
Anxiety and depression: Main determinants of health-related quality of life in
Autonomic and Cognitive dysfunction in Parkinson's disease.
Caregiver burden in Parkinson's disease.
Determinants of quality of life in Brazilian patients with Parkinson's disease.
Dopamine: so last century
Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version.
Sleep disorders in Parkinson's disease: facts and new perspectives.

  Publications in 2006
A longitudinal study of patients with Parkinson's disease (ELEP): aims and methodology (article in spanish)
A pilot study on a specific measure for sleep disorders in Parkinson's disease: SCOPA-Sleep
No correlation between the clinical severity of autonomic symptoms (SCOPA-AUT) and electrophysiological test abnormalities in advanced Parkinson's disease

  Publications in 2005
The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure.